{"id":"thiazide-diuretics","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Hypokalemia"},{"rate":"5-10","effect":"Hyperglycemia"},{"rate":"5-10","effect":"Hyperuricemia"},{"rate":"1-5","effect":"Hyponatremia"},{"rate":"5-15","effect":"Hypotension"},{"rate":"<1","effect":"Ototoxicity (high doses)"},{"rate":"1-3","effect":"Photosensitivity"}]},"_chembl":{"chemblId":"CHEMBL1054","moleculeType":"Small molecule","molecularWeight":"380.66"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Thiazides block the sodium-chloride cotransporter (NCC) in the distal convoluted tubule, preventing electrolyte reabsorption and promoting osmotic diuresis. This reduces intravascular volume and total body sodium, leading to decreased blood pressure. Over time, they also cause mild vasodilation through unknown mechanisms, contributing to sustained antihypertensive effects.","oneSentence":"Thiazide diuretics inhibit sodium and chloride reabsorption in the distal convoluted tubule of the nephron, increasing urine output and reducing blood volume and blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:12:21.789Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Edema associated with congestive heart failure"},{"name":"Edema associated with hepatic cirrhosis"},{"name":"Edema associated with renal disease"}]},"trialDetails":[{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT07469722","phase":"PHASE2, PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":"Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect","enrollment":128},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":"Heart Failure","enrollment":1090},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT06381934","phase":"NA","title":"Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-05-06","conditions":"Thiazide Associated Hyponatremia","enrollment":136},{"nctId":"NCT03892148","phase":"PHASE4","title":"Protocol of Diuretics Use in Congestive Therapy in Heart Failure","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-05-17","conditions":"Heart Failure, Acute Heart Failure, Chronic Heart Failure","enrollment":299},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT05171686","phase":"PHASE4","title":"Diuretics and Volume Overload in Early CKD","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2023-02-01","conditions":"Chronic Kidney Disease, Hypertension","enrollment":49},{"nctId":"NCT07271420","phase":"PHASE4","title":"Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2020-01-01","conditions":"Hypertension, Peritoneal Dialysis, End Stage Kidney Disease (ESRD)","enrollment":40},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT07199088","phase":"NA","title":"Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-10-11","conditions":"Acute Decompensated Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic","enrollment":320},{"nctId":"NCT02546583","phase":"PHASE1","title":"Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-08-31","conditions":"Heart Failure","enrollment":458},{"nctId":"NCT06092437","phase":"NA","title":"Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients","status":"RECRUITING","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-02-27","conditions":"Heart Failure Acute","enrollment":466},{"nctId":"NCT02373163","phase":"PHASE4","title":"INTERVENCION Trial","status":"COMPLETED","sponsor":"Prevencion","startDate":"2014-09-01","conditions":"Blood Pressure, High","enrollment":166},{"nctId":"NCT01679132","phase":"NA","title":"BAROSTIM NEO Hypertension Pivotal Trial","status":"SUSPENDED","sponsor":"CVRx, Inc.","startDate":"2013-04-12","conditions":"Uncontrolled Hypertension","enrollment":10},{"nctId":"NCT01471834","phase":"NA","title":"Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2011-06","conditions":"High Blood Pressure","enrollment":40},{"nctId":"NCT05542056","phase":"","title":"Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-09-26","conditions":"Thiazide-induced Hyponatremia (TIH)","enrollment":232},{"nctId":"NCT05753059","phase":"PHASE1","title":"Mechanisms of Diuretic Resistance in Heart Failure, Aim 2","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-08-10","conditions":"Heart Failure","enrollment":50},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT06251713","phase":"NA","title":"Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-07-31","conditions":"Acute Kidney Injury, Cardiac Surgery, Venous Congestion","enrollment":40},{"nctId":"NCT04927299","phase":"PHASE3","title":"Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2022-06-30","conditions":"Essential Arterial Hypertension","enrollment":163},{"nctId":"NCT06362668","phase":"NA","title":"EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2024-05-17","conditions":"Acute Decompensated Heart Failure","enrollment":12},{"nctId":"NCT06608472","phase":"PHASE3","title":"Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-11-30","conditions":"Essential Arterial Hypertension","enrollment":292},{"nctId":"NCT00690521","phase":"NA","title":"A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2004-10-26","conditions":"Congestive Heart Failure","enrollment":8},{"nctId":"NCT06450327","phase":"","title":"Resistant Hypertension An Open, Complicated (\"Cum Plicare\") or Complex (\"Cum Plexus\") Syndrome?","status":"RECRUITING","sponsor":"University of Campinas, Brazil","startDate":"2024-08-27","conditions":"Hypertension, Resistant Hypertension","enrollment":80},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT06414759","phase":"PHASE4","title":"Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Acute Decompensated Heart Failure, Volume Overload, Edema","enrollment":110},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT00131846","phase":"PHASE4","title":"Diuretics In the Management of Essential Hypertension (DIME) Study","status":"COMPLETED","sponsor":"Kyoto University","startDate":"2004-04","conditions":"Hypertension","enrollment":1130},{"nctId":"NCT02185417","phase":"PHASE3","title":"Diuretic Comparison Project","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2016-06-15","conditions":"Hypertension","enrollment":20723},{"nctId":"NCT03179163","phase":"PHASE1, PHASE2","title":"Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans","status":"TERMINATED","sponsor":"Penn State University","startDate":"2016-07-20","conditions":"Hypertension,Essential","enrollment":10},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT04036409","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients","status":"UNKNOWN","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-05","conditions":"Ischemic Stroke, Blood Pressure, Cognitive Impairment","enrollment":4369},{"nctId":"NCT02665117","phase":"NA","title":"Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2015-01","conditions":"Hypertension","enrollment":61},{"nctId":"NCT05222191","phase":"PHASE2","title":"Spironolactone in CKD Enabled by Chlorthalidone: PILOT","status":"UNKNOWN","sponsor":"Indiana Institute for Medical Research","startDate":"2022-02-01","conditions":"Renal Insufficiency, Chronic Hypertension","enrollment":24},{"nctId":"NCT04354376","phase":"","title":"Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-09-22","conditions":"Hypertension","enrollment":40048},{"nctId":"NCT05840536","phase":"PHASE4","title":"Combination Diuretic Therapy for Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Ochsner Health System","startDate":"2014-05","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT02711670","phase":"NA","title":"Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium","status":"COMPLETED","sponsor":"VA New York Harbor Healthcare System","startDate":"2014-02","conditions":"Kidney Stones","enrollment":10},{"nctId":"NCT03999216","phase":"PHASE4","title":"Comparing Diuretic Strategies in Hospitalized Heart Failure","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2023-07","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT04860011","phase":"PHASE3","title":"DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance","status":"UNKNOWN","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2021-04-27","conditions":"Heart Failure","enrollment":61},{"nctId":"NCT05087940","phase":"","title":"Treatment of Resistant Hypertension: Cohort Study","status":"COMPLETED","sponsor":"Galenika AD Beograd","startDate":"2021-06-01","conditions":"Resistant Hypertension","enrollment":731},{"nctId":"NCT03261375","phase":"NA","title":"To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension","status":"COMPLETED","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2021-01-19","conditions":"Hypertension","enrollment":205},{"nctId":"NCT04129840","phase":"NA","title":"Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-03-05","conditions":"Arterial Hypertension","enrollment":1268},{"nctId":"NCT01647932","phase":"PHASE3","title":"Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure","status":"COMPLETED","sponsor":"Spanish Society of Internal Medicine","startDate":"2014-10","conditions":"Heart Failure","enrollment":232},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT05470764","phase":"PHASE1","title":"Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Darnitsa Pharmaceutical Company","startDate":"2021-05-30","conditions":"Bioequivalence, Healthy Subjects","enrollment":52},{"nctId":"NCT05464745","phase":"PHASE1","title":"Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Darnitsa Pharmaceutical Company","startDate":"2021-05-19","conditions":"Bioequivalence, Healthy Subjects","enrollment":42},{"nctId":"NCT05352633","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-07-18","conditions":"Blood Pressure","enrollment":710},{"nctId":"NCT00896389","phase":"PHASE4","title":"Salt Loading and Thiazide Intervention Study","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2009-10","conditions":"Hypertension","enrollment":124},{"nctId":"NCT04192110","phase":"PHASE4","title":"Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2020-08-11","conditions":"Chronic Kidney Disease","enrollment":""},{"nctId":"NCT04952051","phase":"PHASE3","title":"Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2014-07-01","conditions":"Hypertension","enrollment":1000},{"nctId":"NCT02824718","phase":"PHASE2","title":"Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-06","conditions":"Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment","enrollment":16},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03574857","phase":"PHASE4","title":"Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2018-06-01","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure Acute","enrollment":5},{"nctId":"NCT01206062","phase":"NA","title":"Systolic Blood Pressure Intervention Trial","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-10","conditions":"Hypertension","enrollment":9361},{"nctId":"NCT02699125","phase":"PHASE4","title":"Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-01","conditions":"Obstructive Sleep Apnea","enrollment":41},{"nctId":"NCT02765009","phase":"NA","title":"Effects of Fluid Balance Control in Critically Ill Patients","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2016-06-01","conditions":"Fluid Shifts, Critical Care","enrollment":1411},{"nctId":"NCT04465123","phase":"PHASE3","title":"Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2020-08-13","conditions":"Acute Heart Failure, Acute Kidney Injury","enrollment":100},{"nctId":"NCT00535925","phase":"PHASE4","title":"Nephropathy In Type 2 Diabetes and Cardio-renal Events","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2005-10","conditions":"Diabetic Nephropathy","enrollment":850},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT03246555","phase":"PHASE3","title":"Fimasartan in the Senior Subjects","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2016-07-15","conditions":"The Elderly (≥ 70 Years) With Essential Hypertension","enrollment":241},{"nctId":"NCT04242758","phase":"PHASE4","title":"Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy","status":"UNKNOWN","sponsor":"University of Pisa","startDate":"2019-06-04","conditions":"Renal Function Disorder, Glucose Metabolism Disorders","enrollment":30},{"nctId":"NCT02606253","phase":"PHASE4","title":"Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2016-02","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT01720160","phase":"NA","title":"BAROSTIM® Hope for Heart Failure Study","status":"UNKNOWN","sponsor":"CVRx, Inc.","startDate":"2012-11","conditions":"Heart Failure","enrollment":98},{"nctId":"NCT03921736","phase":"PHASE4","title":"Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.","status":"COMPLETED","sponsor":"Anna Posadzy-Małaczyńska","startDate":"2000-01-10","conditions":"Hypertension, Hyperuricemia, Menopause","enrollment":180},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT03195023","phase":"PHASE4","title":"Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)","status":"UNKNOWN","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2015-06","conditions":"Renal Insufficiency, Chronic, Proteinuria","enrollment":106},{"nctId":"NCT00353652","phase":"PHASE4","title":"Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2005-01","conditions":"Hypertension","enrollment":166},{"nctId":"NCT00745953","phase":"PHASE4","title":"Regression of Fatty Heart by Valsartan Therapy","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-08","conditions":"Metabolic Syndrome, Lipotoxicity","enrollment":""},{"nctId":"NCT02412761","phase":"NA","title":"Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-06","conditions":"Essential Hypertension","enrollment":42},{"nctId":"NCT02814552","phase":"NA","title":"OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-06-18","conditions":"High Blood Pressure","enrollment":47},{"nctId":"NCT02614807","phase":"NA","title":"Protein Supplementation in Thiazide-induced Hyponatremia","status":"WITHDRAWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2016-06","conditions":"Hyponatremia, Hypertension, Blood Pressure","enrollment":""},{"nctId":"NCT00246519","phase":"PHASE4","title":"Pharmacogenomic Evaluation of Antihypertensive Responses","status":"COMPLETED","sponsor":"University of Florida","startDate":"2005-10","conditions":"Hypertension","enrollment":1701},{"nctId":"NCT02875886","phase":"PHASE4","title":"DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2016-09","conditions":"Chronic Kidney Disease","enrollment":28},{"nctId":"NCT01996085","phase":"NA","title":"Non-invasive Haemodynamic Assessment in Hypertension","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2013-01","conditions":"Arterial Hypertension","enrollment":144},{"nctId":"NCT00904488","phase":"PHASE4","title":"Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-10","conditions":"Acute Decompensated Heart Failure","enrollment":11},{"nctId":"NCT02502981","phase":"PHASE4","title":"Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD","status":"UNKNOWN","sponsor":"University Hospital Birmingham","startDate":"2014-06","conditions":"Renal Insufficiency, Chronic, Cardio-Renal Syndrome","enrollment":154},{"nctId":"NCT03082742","phase":"NA","title":"The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2015-08-01","conditions":"Secondary Hyperparathyroidism, Chronic Kidney Disease","enrollment":52},{"nctId":"NCT00858702","phase":"PHASE4","title":"Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2005-02","conditions":"Hypertension","enrollment":105},{"nctId":"NCT02591628","phase":"NA","title":"Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2015-08","conditions":"Hypertension","enrollment":2027},{"nctId":"NCT00994253","phase":"PHASE4","title":"Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics","status":"WITHDRAWN","sponsor":"Corewell Health East","startDate":"2009-08","conditions":"Hypertension, Diabetes Type 2","enrollment":""},{"nctId":"NCT01921829","phase":"PHASE4","title":"Protocolized Diuretic Strategy in Cardiorenal Failure","status":"TERMINATED","sponsor":"Kelly V. Liang, MD","startDate":"2013-11","conditions":"Cardiac Failure, Renal Failure, Kidney Failure","enrollment":19},{"nctId":"NCT01748123","phase":"PHASE4","title":"EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2016-08","conditions":"Hypertension","enrollment":""},{"nctId":"NCT00250562","phase":"PHASE3","title":"A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-10","conditions":"Hypertension","enrollment":1171},{"nctId":"NCT01891513","phase":"","title":"ACE Inhibitors Combined With Exercise for Seniors - Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-01","conditions":"Hypertension, Aging","enrollment":104},{"nctId":"NCT02644395","phase":"PHASE3","title":"Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2013-01-18","conditions":"Hypertension, Kidney Transplantation","enrollment":49},{"nctId":"NCT02294539","phase":"PHASE4","title":"Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients","status":"COMPLETED","sponsor":"Chong-Jin Kim","startDate":"2014-08","conditions":"Hypertension","enrollment":231},{"nctId":"NCT01056731","phase":"PHASE4","title":"A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-02","conditions":"High Blood Pressure","enrollment":253},{"nctId":"NCT02817503","phase":"PHASE4","title":"Feasibility Study of the Intensive Systolic Blood Pressure Control","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2015-12","conditions":"Hypertension, Hyperhomocysteinemia","enrollment":100},{"nctId":"NCT00306696","phase":"PHASE4","title":"Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-10","conditions":"Diabetes Mellitus","enrollment":388},{"nctId":"NCT01904695","phase":"EARLY_PHASE1","title":"Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2013-08","conditions":"Primary Hypertension, Hypertension, Resistant to Conventional Therapy","enrollment":192},{"nctId":"NCT02646397","phase":"PHASE4","title":"Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension","status":"UNKNOWN","sponsor":"Shanghai Changzheng Hospital","startDate":"2016-02","conditions":"Chronic Kidney Disease","enrollment":508},{"nctId":"NCT01258764","phase":"NA","title":"Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril","status":"COMPLETED","sponsor":"Scripps Translational Science Institute","startDate":"2010-11","conditions":"Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design","enrollment":2},{"nctId":"NCT00388388","phase":"PHASE2","title":"Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects","status":"TERMINATED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2007-03","conditions":"Pre-hypertension, Pre-diabetes","enrollment":1},{"nctId":"NCT01977430","phase":"PHASE4","title":"Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function","status":"UNKNOWN","sponsor":"Corporacion Parc Tauli","startDate":"2013-11","conditions":"Chronic Kidney Insufficiency, Hemodialysis Treatment, Diuresis Preserved","enrollment":36},{"nctId":"NCT01404078","phase":"NA","title":"Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium","status":"COMPLETED","sponsor":"St. John's Research Institute","startDate":"2010-04","conditions":"Ischemic Heart Disease, Ischemic Stroke, Peripheral Vascular Disease","enrollment":518},{"nctId":"NCT01635231","phase":"NA","title":"The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects","status":"COMPLETED","sponsor":"Regional Hospital Holstebro","startDate":"2012-07","conditions":"Nephropathy","enrollment":24},{"nctId":"NCT00689819","phase":"NA","title":"Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2008-10","conditions":"Hypertension, High Blood Pressure, Ventricular Hypertrophy","enrollment":123}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HEPATIC ENZYME INCREASED"},{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":1,"reaction":"BLOOD PRESSURE INADEQUATELY CONTROLLED"},{"count":1,"reaction":"BLOOD TRIGLYCERIDES INCREASED"},{"count":1,"reaction":"BRONCHOSPASM"},{"count":1,"reaction":"CHOLELITHIASIS"},{"count":1,"reaction":"CONTINUOUS HAEMODIAFILTRATION"}],"_approvalHistory":[],"publicationCount":2397,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["benidipie, thiazide diuretics"],"phase":"marketed","status":"active","brandName":"thiazide diuretics","genericName":"thiazide diuretics","companyName":"Seiji Umemoto, M.D., Ph.D.","companyId":"seiji-umemoto-m-d-ph-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thiazide diuretics inhibit sodium and chloride reabsorption in the distal convoluted tubule of the nephron, increasing urine output and reducing blood volume and blood pressure. Used for Hypertension, Edema associated with congestive heart failure, Edema associated with hepatic cirrhosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}